Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the ...

The trials met both their primary and key secondary endpoints, demonstrating that treatment with nemolizumab resulted in significant and clinically meaningful improvements in itch and skin nodules at ...

Pet Medicated Shampoo Market Size Was Valued at USD 573.89 Million in 2023, and is Projected to Reach USD 975.35 Million by ...

It's still early science -- studies in mice and in human cells -- but researchers are on the trail of an effective new ...

Experiencing a burning sensation in the genital area is uncomfortable and concerning. While many people immediately associate ...

Translational research and innovative therapies have opened new frontiers in understanding atopic dermatitis (AD), focusing on key areas such as abnormal immune responses, pruritus, microbial ...

Infusion-related hypersensitivity reactions, including mucocutaneous erythema and pruritus, were reported during induction. If a severe hypersensitivity reaction occurs, discontinue Omvoh immediately ...

Incyte was developing INCB000547 for chronic pruritus. Joining Incyte’s cancer cut is iTeos ... An exploratory analysis of ...

Linerixibat is a small molecule commercialized by GSK, with a leading Phase III program in Pruritus. According to Globaldata, it is involved in 15 clinical trials, of which 12 were completed, and 3 ...

Could itchy skin be a thing of the past? Imagine a simple daily cream that quiets the inflammatory storm of millions ...

Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular”), a biopharmaceutical company committed to improving vision in the real world ...

Restless legs syndrome (RLS) is a condition that causes an uncontrollable urge to move your legs, often accompanied by ...